Loading…
Haemonetics Corporation announced a definitive agreement to acquire all outstanding shares of OpSens, Inc. for CAD $2.90 per share in an all-cash transaction valued at approximately USD $253 million. OpSens provides fiber optic sensor technology for interventional cardiology.